FLT1 and cancer: We previously isolated a cancer neovessel-specific peptide, Ala-Pro-Arg-Pro-Gly (APRPG containing the PRP motif) [10], [11], which selectively binds to vascular endothelial growth factor receptor-1 (VEGFR-1) [12].